Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

Myeloid Leukemia ◽

Refractory Acute Myeloid Leukemia ◽

Reduced Intensity ◽

370: Fludarabine-busulphan reduced intensity conditioning (RIC) identical sibling allogeneic stem cell transplantation (allo-SCT) in high risk acute myeloid leukemia and myelodisplastic syndrome

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2006.12.375 ◽

2007 ◽

Vol 13 (2) ◽

pp. 134-135 ◽

Cited By ~ 1

Author(s):

D. Valcarcel ◽

R. Martino ◽

J. Martin ◽

C. Ferra ◽

A. Sampol ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Reduced Intensity ◽

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

European Journal Of Haematology ◽

10.1111/j.1600-0609.2011.01703.x ◽

2011 ◽

Vol 88 (1) ◽

pp. 52-60 ◽

Cited By ~ 39

Author(s):

Stefanie Buchholz ◽

Elke Dammann ◽

Michael Stadler ◽

Juergen Krauter ◽

Gernot Beutel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Cytoreductive Treatment ◽

Refractory Acute Myeloid Leukemia ◽

Reduced Intensity ◽

A phase II trial of sequential treatment with cytoreductive therapy and reduced intensity conditioning allogeneic stem cell transplantation for relapsed/ refractory acute myeloid leukemia, high risk myelodysplasia, or other high risk myeloid malignancies

http://isrctn.org/> ◽

10.1186/isrctn32336114 ◽

2012 ◽

Author(s):

Jamie Cavenagh

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase Ii Trial ◽

Refractory Acute Myeloid Leukemia ◽

Reduced Intensity ◽

Efficacy of Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia After Myeloablative and Reduced-intensity Conditioning

Oncopediatrics ◽

10.15690/onco.v2.i4.1466 ◽

2015 ◽

Vol 2 (4) ◽

pp. 396-403 ◽

Cited By ~ 3

Author(s):

S.N. Bondarenko ◽

◽

S.V. Razumova ◽

N.V. Stancheva ◽

E.V. Semenova ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Children And Adolescents ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Reduced Intensity ◽

New sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem-cell transplantation in very high-risk acute myeloid leukemia

American Journal of Hematology ◽

10.1002/ajh.22029 ◽

2011 ◽

Vol 86 (7) ◽

pp. 619-621 ◽

Cited By ~ 3

Author(s):

Thomas Cluzeau ◽

Muriel De Matteis ◽

Nicolas Mounier ◽

Lionel Mannone ◽

Nicole Gratecos ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Very High ◽

Reduced Intensity ◽

The role of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): a donor versus no donor comparison

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6540 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6540-6540

Author(s):

M. Mohty ◽

H. de Lavallade ◽

C. Faucher ◽

N. Vey ◽

J.-A. Gastaut ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

No Donor ◽

Reduced Intensity ◽

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

Annals of Hematology ◽

10.1007/s00277-003-0654-9 ◽

2003 ◽

Vol 82 (6) ◽

pp. 336-342 ◽

Cited By ~ 71

Author(s):

N. Kr�ger ◽

M. Bornh�user ◽

G. Ehninger ◽

R. Schwerdtfeger ◽

H. Biersack ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Secondary Acute Myeloid Leukemia ◽

Reduced Intensity ◽

The role of reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) in patients with acute myeloid leukemia (AML): A donor versus no donor comparison

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2004.12.009 ◽

2005 ◽

Vol 11 (2) ◽

pp. 3

Author(s):

H. De Lavallade ◽

M. Mohty ◽

C. Faucher ◽

N. Vey ◽

D. Coso ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

No Donor ◽

Reduced Intensity ◽

Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia

Haematologica ◽

10.3324/haematol.10867 ◽

2007 ◽

Vol 92 (4) ◽

pp. 533-541 ◽

Cited By ~ 63

Author(s):

D. Blaise ◽

N. Vey ◽

C. Faucher ◽

M. Mohty

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Current Status ◽

Reduced Intensity ◽

Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed By Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.299 ◽

2014 ◽

Vol 20 (2) ◽

pp. S183

Author(s):

Stacey Zahler ◽

Sumith Roy ◽

Angela Ricci ◽

Erin Morris ◽

Lauren Harrison ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Children And Adolescents ◽

Myeloid Leukemia ◽

Gemtuzumab Ozogamicin ◽

Reduced Intensity ◽